Diethylstilbestrol decreased adrenal cholesterol and corticosterone in rats

作者：Haeno Satoko; Maeda Naoyuki; Yagi Takeshi; Tahata Sachi; Sato Michiko; Sakaguchi Kanako; Miyasho Taku; Ueda Hiromi; Yokota Hiroshi^*

来源：Journal of Endocrinology, 2014, 221(2): 261-272.

DOI：10.1530/JOE-13-0460

• diethylstilbestrol
• endocrine disruptor
• corticosterone
• adrenal insufficiency
• cholesterol

The synthetic oestrogen diethylstilbestrol (DES), which is known to bind oestrogen receptors (ERs), has been reported to have adverse effects on endocrine homeostasis; however, the molecular mechanisms underlying these effects are poorly understood. In this study, we treated rats with DES and found high levels of this compound in the liver, adrenal glands and pituitary gland, as compared with other tissues. We have also detected early adverse effects of DES in the adrenal glands. The adrenal glands of rats treated with DES (340 mg/kg body weight every 2 days) for 2 weeks showed increased weight and size and a decreased fat droplet size. Following 1 week of treatment with DES, the blood and adrenal corticosterone levels were substantially decreased without any histological alterations. The levels of the precursors for corticosteroid biosynthesis in the adrenal glands were also decreased, as determined using mass spectroscopy. Cholesterol, the principal material of corticosteroid biosynthesis, decreased substantially in the adrenal glands after only 1 week of treatment with DES. In conclusion, cholesterol insufficiency results in a reduction in adrenal corticosterone biosynthesis, which may lead to endocrine dysfunction, such as reproductive toxicity.

• 出版日期2014-5